Lea is a member of Newton’s equity research team. In her current role, she is responsible for covering life science tools equities.

Joined industry
Joined the Group

Lea joined Newton in September 2021, following the integration of Mellon Investments Corporation’s equity and multi-asset capabilities into the Newton Investment Management Group. Prior to her role as an analyst, Lea was a member of the firm’s research associate team.

Lea has a BS in Operations Research from Cornell University.